Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Cytodynamite's Profile
Displaying 1-50 of 389 result(s).
CYDY CytoDyn Inc
04/27/2020 6:42:03 AM
There was not an early PR for the V (1)
CYDY CytoDyn Inc
04/27/2020 6:03:04 AM
So we will get another delay for BL (3)
CYDY CytoDyn Inc
04/26/2020 5:23:43 PM
I would understand that. If we dont (3)
CYDY CytoDyn Inc
04/26/2020 5:01:41 PM
It's entirely possible we see a sho
CYDY CytoDyn Inc
04/26/2020 4:03:11 PM
Love your posts!!!!!
CYDY CytoDyn Inc
04/26/2020 1:03:07 PM
This comes from Germany´s worst an (1)
CYDY CytoDyn Inc
04/26/2020 1:48:15 AM
https://m.facebook.com/savesarahgr (2)
CYDY CytoDyn Inc
04/24/2020 12:13:46 PM
Me too Diddy....
CYDY CytoDyn Inc
04/24/2020 8:53:06 AM
It was me, and I would love to dona (2)
CYDY CytoDyn Inc
04/24/2020 7:22:25 AM
If Nader explains to us on Monday w (2)
CYDY CytoDyn Inc
04/24/2020 6:13:17 AM
They better have filed it, yes.
CYDY CytoDyn Inc
04/24/2020 3:55:14 AM
Talking about 300$ we would be the (1)
CYDY CytoDyn Inc
04/23/2020 12:59:11 PM
Remdesivir is not working. Lalezari (2)
CYDY CytoDyn Inc
04/23/2020 12:42:45 PM
I am going to donate $5,000 to what
CYDY CytoDyn Inc
04/23/2020 9:43:43 AM
I smell absolutely nothing despite (3)
CYDY CytoDyn Inc
04/23/2020 8:02:22 AM
Great article https://www.google.co (9)
CYDY CytoDyn Inc
04/23/2020 2:43:17 AM
Our trial will do better. Question
CYDY CytoDyn Inc
04/20/2020 4:41:12 PM
Nice to see to be able to rise 15% (1)
CYDY CytoDyn Inc
04/20/2020 9:30:47 AM
Pushing ask down.....as I said....w
CYDY CytoDyn Inc
04/20/2020 9:20:48 AM
I couldnt care less. Roughly $20m i (2)
CYDY CytoDyn Inc
04/20/2020 9:16:55 AM
So this would roughly be a $25/ buy (2)
CYDY CytoDyn Inc
04/20/2020 9:11:55 AM
OTCX pushes ASK down to $2.30, is t
CYDY CytoDyn Inc
04/18/2020 10:49:55 AM
Nader has been promising the BLA su
CYDY CytoDyn Inc
04/18/2020 5:20:56 AM
As one being overly critical and te (11)
CYDY CytoDyn Inc
04/17/2020 11:10:46 AM
That is not true. He did not order. (1)
CYDY CytoDyn Inc
04/17/2020 10:57:03 AM
I honestly don't see approval for u (1)
CYDY CytoDyn Inc
04/17/2020 10:41:52 AM
I expect absolutely nothing from to
CYDY CytoDyn Inc
04/17/2020 9:28:24 AM
L2 indicates at least another start (1)
CYDY CytoDyn Inc
04/17/2020 2:10:43 AM
Gilead PR and market reactions show
CYDY CytoDyn Inc
04/15/2020 9:34:45 AM
Sp falls like a rock......$2.13
CYDY CytoDyn Inc
04/15/2020 9:19:15 AM
L2 looks like $2.50 will break very
CYDY CytoDyn Inc
04/15/2020 8:21:40 AM
You, as many here, tend to misunder (9)
CYDY CytoDyn Inc
04/15/2020 6:28:18 AM
Both PRs won't move the needle imo.
CYDY CytoDyn Inc
04/15/2020 4:56:26 AM
The next leg will come after substa (1)
CYDY CytoDyn Inc
04/14/2020 1:22:27 PM
Is there a link to the interview? C
CYDY CytoDyn Inc
04/14/2020 9:39:45 AM
SP takes a dive below $2.50. Correc (3)
CYDY CytoDyn Inc
04/14/2020 9:07:42 AM
I said in February that I don't exp (2)
CYDY CytoDyn Inc
04/14/2020 6:22:47 AM
Didn´t Nader tell shareholders tha
CYDY CytoDyn Inc
04/14/2020 5:28:04 AM
Will we get PR today? 33 minutes to (1)
CYDY CytoDyn Inc
04/13/2020 10:58:27 AM
Trading pattern the same every day.
CYDY CytoDyn Inc
04/13/2020 3:51:51 AM
German markets are closed today. Th (1)
CYDY CytoDyn Inc
04/11/2020 3:57:02 AM
Is it naive to hope for approval to (1)
CYDY CytoDyn Inc
04/09/2020 1:36:01 PM
Anyone expecting emergency approval
CYDY CytoDyn Inc
04/09/2020 11:46:23 AM
My biggest concern as well. BLA sho
CYDY CytoDyn Inc
04/09/2020 11:40:04 AM
$2.85 is really great keeping in mi (2)
CYDY CytoDyn Inc
04/09/2020 6:22:30 AM
ABSOLUTELY GROUNDBREAKING NEWS! Can (6)
CYDY CytoDyn Inc
04/09/2020 6:01:32 AM
Severely Ill COVID-19 Patient at Le
CYDY CytoDyn Inc
04/08/2020 6:03:13 AM
Why is there no proper PR about the (1)
CYDY CytoDyn Inc
04/07/2020 7:49:20 AM
Thanks. Not enough data....surprise (2)
CYDY CytoDyn Inc
04/06/2020 4:41:00 PM
It's a joke that FDA wants us to in (2)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • How Poor Blood Flow Influences Cancer Progression
  • Potts Law Firm Represents Coach Istvan Urbanyi After Exit
  • Strengthening Service with Curie Technologies Integration
  • La-Z-Boy's Impressive Q1 Performance: Sales and Margins Rising
  • Legal Action Against Altimmune, Inc.: Understanding Your Options
  • PalmCorp Construction Unveils Stunning $17 Million Estate
  • enCore Energy Corp. to Offer $75 Million Convertible Senior Notes
  • LanzaTech's Q2 Financial Results Highlight Growth and Strategy
  • Permian Basin Royalty Trust Resolves Litigation with Blackbeard
  • PBF Energy Names Joseph Marino as New CFO, Karen Davis Retires
  • Transformative Financial Growth: Jack Henry Embraces Future
  • Veea and Genesys Revolutionize AI Safety Solutions in Construction
  • Leadership Transition at Matthews International: CFO Succession
  • Talos Energy Reveals Exciting Discoveries at Daenerys Well
  • Tesla Faces Class Action Lawsuit Amidst Driving Technology Concerns
  • Orion Energy Systems Implements 1-for-10 Stock Split Strategy
  • Experience Effortless Luxury with Fairmont's New Package
  • Class Action Lawsuit Filed for Centene Corporation (CNC) Investors
  • Chemung Financial Corporation Increases Dividend Payout for Shareholders
  • Luxury Living Redefined: PalmCorp's New Estate Triumph
  • Investor Alert for CTO Realty Growth, Inc. Stakeholders
  • Vivos Therapeutics Reports Growth Amid Strategic Changes
  • Levi & Korsinsky Launches Class Action for XPLR Infrastructure Investors
  • Orion Energy Systems Expands EV Charger Installations Across Massachusetts
  • Investors Alert: Replimune Group Class Action Timeline Updates
  • Canadian Net REIT Reports Impressive 2025 Quarter Results
  • Fiserv Faces Class Action Lawsuit Over Alleged Securities Fraud
  • Capricor Therapeutics Faces Class Action Lawsuit with Deadline
  • Novo Nordisk A/S Class Action Lawsuit: Important Investor Alert
  • Micron's Growth Potential: An Underestimated Opportunity Ahead
  • Arcutis Biotherapeutics Set for Key Investor Conferences
  • Lockheed Martin Faces Class Action: Important Deadline Ahead
  • Ligand Pharmaceuticals to Showcase Insights at Investor Events
  • TrustCo Bank Announces 5.6% Dividend Hike Amid Growth
  • Lineage, Inc. Faces Class Action Lawsuit Over Alleged Fraud
  • RxSight, Inc. Faces Legal Action Over Alleged Securities Fraud
  • Cytokinetics Implements Key Inducement Grants to Support Growth
  • Permian Basin Royalty Trust Resolves Legal Dispute with Blackbeard
  • Celldex's Barzolvolimab Phase 2 Study Yields Unexpected Insights
  • Chemung Financial Corporation's Boost in Quarterly Dividend
  • Leadership Changes at Marten Transport: A New Chapter Ahead
  • Exploring the Growth of MARA Holdings Over the Last Five Years
  • Cytokinetics Unveils Inducement Grants to New Employees
  • Fluent Secures $10.3 Million in Strategic Securities Placement
  • Carlyle Credit Income Fund Reports Strong Q3 Results and Dividends
  • Understanding Qorvo's P/E Ratio in Today's Market
  • Alpine Income Property Trust Announces Q3 2025 Dividend Details
  • Analyzing Applied Optoelectronics' Recent Options Trading Trends
  • CTO Realty Growth Announces Latest Dividends for Investors
  • Exploring Roblox's Market Dynamics and Investment Sentiment
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site